Diagnosis and Management of Dissociative Seizures: John D.C. Mellers
Diagnosis and Management of Dissociative Seizures: John D.C. Mellers
Diagnosis and Management of Dissociative Seizures: John D.C. Mellers
Up to one in five people diagnosed with epilepsy will turn out to have dissociative seizures
(DS) psychologically mediated episodes of altered awareness and/or behaviour that may
mimic any type of epilepsy1,2. These patients are typically treated with antiepileptic
medication for a number of years before the correct diagnosis is made. During this time they
are exposed to significant iatrogenic risks including drug toxicity, teratogenic risk (most
patients are young women) and the risk, in approximately 10%, of receiving emergency
treatment for ‘status’3,4. By the time the correct diagnosis is made many patients and their
families have already adapted their lives to chronic disability. For some, a medical ‘sick role’
seems preferable to a psychiatric one from the start. For the majority, however, years of
inappropriate medical interventions will have reinforced the patients’ view of themselves as
medically disabled. The one factor consistently associated with a better prognosis in this and
other functional disorders is a short duration of illness at the time of diagnosis: in other words,
prompt diagnosis5. How to recognise and treat DS is therefore an important subject for all
clinicians working in the field of epilepsy.
A review in 1997 found no less than 15 synonyms for this disorder6. Some terms
(pseudoseizures, hysterical fits) are clearly pejorative and have been abandoned. Others (non-
epileptic seizures, non-epileptic events, non-epileptic attack disorder) define the condition by
what it is not and may well be interpreted by the patient as suggesting that ‘the doctor doesn’t
know what’s wrong with me’7. Furthermore, some of these terms are ambiguous. Non-
epileptic seizures (NES), for example, is used by some to describe conditions, both medical
and psychiatric, that may be mistaken for epilepsy, while on other occasions NES is used as
a form of shorthand for the psychogenic attacks alone. The debate about terminology is likely
to continue, but in the meantime ICD 108 does in fact provide a perfectly acceptable and
useful label dissociative convulsions. In recognition of the fact that many patients with this
disorder do not actually suffer a ‘convulsion’, the term dissociative seizures is probably
better.
A list of the medical and psychiatric disorders that may be mistaken for epilepsy is given in
Table 1. The clinical features distinguishing epilepsy from paroxysmal cardiological,
neurological and other medical disorders are reviewed elsewhere in this section9,10. Syncope
is probably the most frequent missed diagnosis in non-specialist settings but by the time
patients are referred to specialist epilepsy clinics DS is by far the most important differential
diagnosis1. Indeed, the possibility of DS should be one of the first considerations in a patient
with medically intractable seizures.
Apart from DS a number of psychiatric disorders may occasionally be mistaken for epilepsy
and vice versa. The most important example is panic disorder which may be confused with
Table 1. The differential diagnosis of epilepsy.
_________________________________________________________________________
1. Syncope
- vasovagal
- cardiogenic
2. Neurological
- cerebrovascular
- migraine
- vertigo
- cataplexy
- parasomnias
- movement disorders
- startle-induced phenomena
3. Endocrine and metabolic
- hypoglycaemia
- hypocalcaemia
- hereditary fructose intolerance
- pheochromocytoma
- drugs and alcohol
B. Psychiatric disorders
1. Dissociative seizures
2. Psychiatric disorders that may be mistaken for epilepsy
- panic disorder
- psychosis
- attention deficit hyperactivity disorder
- depersonalisation disorder
3. Factitious disorder
_________________________________________________________________________
partial seizures that feature anxiety as part of the aura11,12. The cognitive symptoms of panic
disorder (specific feared consequences of the attack, such as a fear of choking, having a heart
attack, dying, losing control, etc), the presence of environmental precipitants (crowded
places, queues in supermarkets, etc) and the avoidance of such situations (agoraphobia) help
identify panic. The often unique subjective quality of ‘ictal fear’, abrupt onset without
environmental triggers and the presence of other epileptic semiology are useful in recognising
the epileptic origin of such symptoms in partial seizures. Very rarely, paroxysmal symptoms
in psychosis (hallucinations, thought block) may raise the possibility of epilepsy, and
attentional problems in a child may raise the differential diagnosis of attention deficit
hyperactivity disorder and petit mal seizures. An uncomfortable sense of unreality concerning
one’s self (depersonalisation) or the environment (derealisation) is not uncommon in
temporal lobe seizures. These symptoms may be the primary complaint in depersonalisation
disorder and are a non-specific feature of affective disorder and psychosis13. In psychiatric
disorder these phenomena are usually of relatively gradual onset, prolonged duration and
accompanied by other psychiatric symptoms. Overall, the abrupt onset, brief duration and
highly stereotyped nature of epileptic symptoms help distinguish them from functional
psychiatric disorder.
Factitious disorder and dissociative seizures: the concept of unconscious symptom
generation
Prevalence
From prevalence figures for epilepsy and estimates of the proportion of patients referred to
tertiary clinics who have DS, Benbadis and Allen2 calculated the prevalence of DS to be
between two and 33 per 100,000. However, the true prevalence may be far greater. These
authors based their calculation on the assumption that most patients with DS would find their
way to specialist clinics because their seizures would persist despite AED treatment in
primary care. However, it remains entirely possible that some patients with DS have a
(placebo) response to their first AED prescription and are never referred on for specialist
advice. This possibility is borne out by a recent population-based study that found DS in a
fifth of patients with new-onset seizures, the same proportion of DS reported in specialist
services15.
Demographic characteristics
Some 75% of patients are female3,14,16,17. Seizures typically begin in the late teens or early
20s, although there is a wide range3,14,16. A UK study found a median delay between seizure
onset and diagnosis of three years3, but even longer delays have been reported by others18,19.
Patients with lower educational achievement and of lower socioeconomic groups are
probably overrepresented, although not in comparison with epilepsy.
Clinical assessment
No single semiological feature distinguishes DS from epileptic seizures or vice versa. The
most helpful features, as well as some important pitfalls symptoms that are commonly
mistaken as evidence for epilepsy are listed in Table 2. Epileptic seizures are brief, highly
stereotyped, paroxysmal alterations in neurological function that conform to a number of now
well-described syndromes. Broadly speaking, it is any variation from this clinical picture –
an atypical sequence of events – that will raise the suspicion of epilepsy. Despite 30 years of
videotelemetry there is no reliable shortcut to making the diagnosis: to recognise DS the
clinician must have experience with epilepsy. Some features worth highlighting are the long
duration of DS, their tendency to begin gradually, and to show a waxing and waning of motor
activity followed by an abrupt recovery, asynchronous movements (including side-to-side
head or body movements), eye closure, ictal crying and preserved recall after a period of
unresponsiveness20. An episode of motionless unresponsiveness77 lasting over five minutes
is unlikely to have an organic cause3. Patients with DS commonly report injuries. Friction
burns may be characteristic of DS. Bite injuries are reported in DS, especially to the tip of
the tongue and lip21, but severe scarring is extremely rare. Seizures during sleep are reported
just as frequently in DS (around 50%) as in epilepsy65.
Motor features
Gradual onset common rare
Eyes closed common rare
Thrashing, violent movements common rare
Side-to-side head movement common rare
Pelvic thrusting occasional rare
Opisthotonus, ‘arc de cercle’ occasional very rare
Fluctuating course common very rare
Automatisms rare common
Other features on history which support (and only that) a diagnosis of DS include an absence
of risk factors for epilepsy, a failed response to AEDs and the presence of risk factors for DS
(see below). Here again there are pitfalls. Patients with DS commonly report a significant
past neurological history22 as well as a family history of epilepsy23.
It used to be supposed that the majority of patients with DS also suffered from epilepsy. As
studies have become more sophisticated, however, estimates of the prevalence of comorbid
epilepsy have become ever smaller. Probably no more than 15 or 20% of patients with DS
also have epileptic seizures3,16,18,24. A history of multiple (dissociative) seizure types is given
by 20% of patients with DS16,18.
Psychiatric comorbidity
Studies of psychiatric diagnoses in patients with DS have reported a broad range of
prevalence figures. High rates of depression, anxiety disorder, personality disorder and post-
traumatic disorder have been reported16. Often the presence of such a history will raise
suspicion of DS, but high rates of psychiatric disorder are also seen in association with
epilepsy, at least in those patients with intractable epileptic seizures, and may not help
distinguish the two disorders25-27. A history of previous medically unexplained symptoms is
very common in DS and an important pointer to the diagnosis16.
Ictal observation/examination
An opportunity to observe a seizure may provide invaluable information. Whether the patient
is responsive to verbal requests should be established. Careful note should be taken of the
type and distribution of movements and whether apparent clonic movements are rhythmic
and synchronous (as they usually are in epilepsy) or not (DS). Following a generalised tonic-
clonic seizure the corneal reflex will usually be absent and plantar responses extensor. Pupils
will be unresponsive to light in organic states of impaired consciousness. If the patient’s eyes
are shut the examiner should attempt to open them noting any resistance (DS). A simple test
to look for avoidance of a noxious stimulus is to hold the patient’s hand over their face and
drop it: in DS the patient may be seen to control their arm movement so their hand falls to
one side. If the eyes are open, evidence of visual fixation may be sought in two ways. The
first involves rolling the patient onto their side. In patients with DS the eyes will often be
deviated to the ground. If this is the case, the patient should be rolled onto the other side to
see if the eyes are still directed towards the ground (the ‘Henry and Woodruff sign’)31. A
second useful manoeuvre is to hold a small mirror in front of the patient and look for evidence
of convergent gaze and fixation on the reflection. This procedure will often stop the seizure.
Patients with factitious disorder may learn to produce the ‘correct’ response in all of these
examination procedures.
Investigations
EEG
Unfortunately the EEG still contributes to diagnostic errors in this group of patients. Non-
specific EEG abnormalities are found in up to 15% of healthy individuals and all too often
interpreted as supporting a diagnosis of epilepsy. Narrowly defined epileptiform
abnormalities are much less common, but still encountered in up to 1% of the healthy
population29,30. The risk of a ‘false positive’ EEG is compounded in patients with DS by the
fact that both non-specific and epileptiform EEG abnormalities may be more common in
patients with DS than in healthy individuals, including those who do not have comorbid
epilepsy31. This is almost certainly because a variety of neurological insults associated with
learning difficulties are common in patients with DS and may be associated with EEG
abnormalities in the absence of epilepsy. Interestingly, patients with borderline personality
disorder (also common in DS) have also been reported to have a high prevalence of non-
specific EEG abnormalities32.
VideoEEG telemetry
VideoEEG (vEEG) telemetry is the gold standard investigation. A good quality video which
captures the onset and evolution of the seizure will on its own often allow a confident
diagnosis. The diagnostic electrographic findings are: for epilepsy, 1) ictal epileptiform
discharges; 2) post-ictal slowing; and in DS, 3) an intact alpha rhythm when the patient is
demonstrably unresponsive3. Again there are some traps: in particular, movement artefact
may obscure or even be mistaken for epileptiform discharges. There are documented cases of
patients having their first ever, and possibly only, DS during telemetry, sometimes as an
elaboration of a simple partial seizure33. This underlines the importance wherever possible of
showing the video to an informant to establish that the seizure is representative of the patient’s
habitual attacks. In addition to the cost of vEEG and its restricted availability there are a
number of important clinical limitations. The technique is of limited use in a patient who has
infrequent seizures. Care must be taken in patients who have multiple seizure types to ensure
that an example of each seizure is seen.
Special mention should be made of simple partial seizures and frontal lobe seizures which
are often not accompanied by any electrographic changes on the ictal scalp EEG34,35. Frontal
lobe seizures in particular may have bizarre behavioural features which are now well known
to specialists but may easily mistaken for DS36. The highly stereotyped nature and very brief
duration of the seizures are helpful features on video. If seizures occur in sleep, as they often
do in frontal lobe epilepsy, the EEG will be helpful, demonstrating seizure onset during
electrographically documented sleep. In DS by contrast (around 50% of patients with DS
report seizures arising from sleep)65 the EEG will reveal that the patient wakes and then has
their seizure37.
A number of studies have demonstrated that placebo methods such as intravenous injection
of saline can be used to provoke a seizure in up to 90% of patients with DS38. Clearly these
studies raise ethical concerns related to the use of placebo. Most recently, however,
McGonigal and colleagues have combined simple suggestion with routine photic and
hyperventilation stimuli, fully disclosing the aims of the procedure to patients39. A total of
60% of patients had a DS provoked in this way compared with 33% in a control group who
received identical activation procedures but without suggestion. These authors estimate they
were able to reduce the need for prolonged telemetry admission in 47% of patients.
Provocation may be of particular value in patients who have infrequent seizures and would
otherwise be unsuitable for telemetry. There is a small risk of false positive results with this
technique (provoking a DS in a patient with epilepsy) and it is therefore critical that an
informant who has witnessed the patient’s seizures is available to confirm that the provoked
seizure resembles their habitual seizures.
Ambulatory EEG monitoring and video recordings obtained by patients’ carers may be very
helpful with the accepted and obvious limitations of lacking video correlation in the first and
usually failing to capture seizure onset in the second40.
Serum prolactin
Serum prolactin rises after tonic-clonic epileptic seizures, peaking between 20 and 30 minutes
following the seizure41. The post-ictal prolactin level should be compared with a baseline
measure taken at approximately the same time of day. A prolactin rise is less reliable
following complex partial seizures, may be absent following serial epileptic seizures or in
status epilepticus, and is not seen following simple partial seizures. False positive rises are
now known to occur following syncope42 and, more significantly, DS43 and the test is falling
out of favour. However, a negative finding after an apparent tonic-clonic seizure may still be
very helpful. A recent study has reported higher creatine kinase levels in patients with tonic-
clonic status compared with DS status but again there were false positives and negatives67.
Dissociation
For practical purposes, dissociation may be defined as a psychologically mediated alteration
of awareness and/or control of neurological function. Some have argued for more specific
uses of the term44, but defined in this way dissociation encompasses a spectrum of mental
processes including normal phenomena, such as focused or divided attention (e.g. ‘domestic
deafness’, mental absorption), and pathological states involving perceptual, cognitive and
motor function. The advantage of such a definition is that, by explicitly assuming (and it is
an assumption) that dissociative disorders lie on a continuum with normal experience, it
facilitates an empathic understanding of what might otherwise seem unintelligible, if not
frankly unbelievable, behaviour. This is equally important for professionals, patients and
carers.
The psychophysiological basis for dissociative states is not understood. Many patients with
DS describe becoming gradually cut off or distant from their environment and experience
symptoms of autonomic arousal during their seizures. This suggests that for some patients,
DS may represent a dissociative response to paroxysmal physiological arousal triggered by
intense emotion. Some patients may even be aware of ‘giving in’ to a trance-like state to
escape from distressing emotions80. Most patients, however, deny emotional symptoms in
their attack (DS may be likened to ‘panic attacks without panic’)66, the hypothesis being that
the triggering emotion is concealed by the dissociative state (for Freud this was the primary
gain of hysterical symptoms). However, clinical experience suggests that a proportion of
patients who initially deny triggers for their attacks are eventually able to recognise highly
specific and emotive cues (for example related to traumatic past experiences). Clearly, this
model of dissociative mechanisms gives rise to a number of testable hypotheses which require
further research.
Psychological Social
Predisposing Perception of childhood Adverse (abusive) experiences in
experience as adverse childhood
Mood disorder
Angry/confused/anxious
reaction to diagnosis
There is no evidence at present for biological factors which are therefore not listed in the table.
However, there may be genetic influences on relevant personality attributes, coping styles and traits.
(Adapted from Binzer et al45)
One study has presented evidence of adverse events in the year prior to onset of DS which
might be regarded as precipitating factors for the disorder45. Once the disorder is established
a number of maintaining factors may operate. Agoraphobic avoidance is more common in
patients with DS than in epilepsy and serves to heighten anxiety about having seizures which
in turn makes seizures more likely66. Anxiety about the seizures will also be fuelled by
conflicting diagnoses and advice received from the numerous contacts patients have with
doctors, paramedics, accident and emergency staff as well as friends, support groups and the
internet. Finally, for some individuals at least, the benefits of the sick role may provide an
acceptable alternative to the responsibilities of healthy life52, and carers, unwittingly or
otherwise, may play an important role in perpetuating disability. The stigma attached to
mental illness undoubtedly has an important role in shaping the medical presentation of
somatoform disorders and contributes to the reluctance many patients have in accepting
psychiatric treatment.
Management
Next, an intelligible explanation of what the patient does have is required. The concept of
dissociation can be explained as involuntary episodes of ‘switching off’ or going into a
‘trance’. Examples of selective attention (mental absorption – not hearing one’s name called
when reading) and divided attention (travelling home from work and remembering nothing
of the journey) can be used to illustrate the involuntary, unconscious nature of dissociative
phenomena and how we can all be unaware, or have no memory of, sensory experience or
complex activities despite perfectly normal neurological function.
2. Reassurance
• They are not suspected of ‘putting on’ the attacks
• The disorder is very common
4. Treatment
• DS may improve simply following correct diagnosis
• Caution that AED withdrawal should be gradual
• Describe psychological treatment
_________________________________________________________________________
Patients often express a fear that they are ‘mad’ and are reassured to hear how common the
problem is and that it is treatable. In trying to answer the question ‘what causes the seizures?’
a helpful approach is to describe the known demographic and aetiological factors as they
apply to that individual, together with a speculative model of how this might be related to
dissociation. For example, one might explain: ‘We don’t fully understand what causes this
disorder but two-thirds of people with it have suffered the sort of traumatic experiences you
have described. We can’t explain the link for certain, but it may be that when people are
exposed to repeated frightening incidents as a child they learn to switch off. Initially this is a
helpful thing for them to do, it protects them emotionally at the time. But it may come back
later in life as these seizures.’ It is important not to suggest abuse as a possible aetiological
factor if this history has not emerged spontaneously for fear of encouraging ‘false memories’.
A description of maintaining factors is especially useful when other aetiological factors are
not apparent. Patients will often recognise that their confusion about the nature of the
seizures, avoidance of situations in which they fear having one, and the protective reactions
of carers together create a ‘vicious circle’ whereby fear of having attacks may eventually
become the most important ‘cause’ of them. A few patients clearly identify stress as a trigger
for individual attacks but most do not. This can be a very difficult issue. It may be helpful to
explain that many patients are initially unable to identify triggers for their attacks but that
these often become apparent with treatment. Further, that when triggers are found they often
turn out to be fleeting stressful or unpleasant thoughts that the patient was barely aware of (or
could not easily remember) that have little to do with their immediate circumstances. It may
be useful to explain that we all think at many different levels at any one time and some of
what we are thinking about is instantly forgotten. By way of illustration, asked to introspect
for a moment, most patients will acknowledge that they have been thinking of other things
while listening to the doctor’s explanations. Examples of the link between physical symptoms
and emotional state, and of the complex automatic behavioural accompaniments to emotions
(as seen with grief or with rage) may help illustrate some of the physical attributes of seizures.
Information about DS is available online through two comprehensive and carefully devised
websites written by neurologists for patients.
Patients who have comorbid epilepsy often pose the most difficult management problems.
Where both types of seizures are ongoing the main challenge will be to clearly identify, with
the patient and carers, the different seizure types: residual uncertainty may undermine
psychological treatment and lead to over-medication in order to ‘play safe’. Showing patients
and carers videos of seizures captured in telemetry is useful but the semiology frequently
changes and the issue often requires regular review. In this situation home videos of seizures
may help to avoid repeating vEEG telemetry.
Treatment
Pharmacotherapy is clearly appropriate for the relatively small proportion of patients with
significant psychiatric comorbidity. Even in those patients without a comorbid psychiatric
disorder that might be expected to respond to anxiolytic or antidepressant treatment, some
authorities advocate using such treatments54. However, a small randomised controlled trial of
sertraline recently failed to show significant benefit71.
For the majority of patients some form of psychological treatment is usually recommended79.
There is relatively little evidence on which to base a decision about what form of therapy is
best, although it is widely supposed that the nature of any associated psychiatric comorbidity
(if any) is an important consideration. In patients with learning difficulties operant
behavioural programmes using simple reward systems are often helpful55,56. The early
literature includes a number of compelling descriptions of insight-oriented, dynamic
psychotherapeutic approaches in patients with a history of DS and sexual abuse57,58. Rusch
and colleagues reported treatment outcome in 33 patients59. Treatment, which included
psychodynamic and cognitive behavioural approaches (mostly in combination), was tailored
to reflect aetiology and comorbid psychiatric diagnoses. In a larger, uncontrolled series,
Mayor et al72 have recently reported outcome in 66 patients who received brief inter-personal
(dynamic) therapy ‘augmented’ with cognitive behavioural techniques. One-quarter of
patients were seizure free after six months. Other reports have described psychoeducational
group therapy60 and eye movement desensitisation61. Variations of therapy based on
psychodynamic, insight-oriented and group-based methods are undoubtedly widely practised
and believed to be effective but controlled studies of such interventions are needed.
The paroxysmal nature of DS, prominent somatic symptoms of arousal in many patients and
an association with agoraphobic avoidant behaviour suggest that techniques developed in
cognitive behavioural therapy (CBT) for the treatment of panic disorder might readily be
adapted for DS59,62. A number of uncontrolled studies have now shown that CBT is associated
with significant improvement63,73,74. Most recently, a randomised controlled trial has
demonstrated a significant advantage of CBT compared with standard outpatient care75.
Patients receiving CBT were three times more likely to become seizure free by the end of
treatment. However, improvement was seen in both CBT and standard treatment groups and
by six months follow-up the difference in outcome was no longer statistically significant. A
second small randomised controlled trial has also suggested the effectiveness of CBT in DS81.
A multicentre RCT is now under way in the UK comparing the effectiveness of standardised
medical care with and without CBT82. Controlled studies of longer-term outcome following
treatment are required, as are comparisons of different treatment approaches, including
evaluations of brief simplified treatments which might be delivered more easily outside
specialist neuropsychiatric services. Techniques developed for post-traumatic stress disorder
and dysfunctional personality traits may also be helpful, but these and other techniques also
require evaluation59,64.
A significant proportion (see below) of patients continues to have seizures despite intensive
treatment. A pragmatic approach in such cases is to offer long term-follow up to provide
support for the patient and their family, social interventions to improve quality of life, and
also to limit the cost and morbidity associated with further unnecessary investigations and
medical interventions.
Outcome
A review of outcome studies5 found that after a mean follow-up period of three years
approximately two-thirds of patients continued to have DS and more than half remained
dependent on social security. Psychiatric treatment has been associated with a positive
outcome in some studies, but not others. A poor prognosis is predicted by a long delay in
diagnosis and the presence of psychiatric comorbidity, including personality disorder. Being
unemployed and in receipt of disability benefits has recently been reported to be a predictor
of poor outcome76.
References
1. SMITH D, DEFALLA BA, CHADWICK DW. The misdiagnosis of epilepsy and the management of refractory
epilepsy in a specialist clinic. Q J Med 1999; 92: 15-23.
2. BENBADIS SR, ALLEN HW. An estimate of the prevalence of psychogenic non-epileptic seizures. Seizure 2000;
9: 280-1.
3. MEIERKORD H, WILL B, FISH D et al. The clinical features and prognosis of pseudoseizures diagnosed using
video-EEG telemetry. Neurology 1991; 41: 1643-6.
4. KRUMHOLZ A, NEIDERMEYR E. Psychogenic seizures: a clinical study with follow-up data. Neurology 1983;
33: 498-502.
5. REUBER M, ELGER CE. Psychogenic nonepileptic seizures: Review and update. Epilepsy Behav 2003; 4:205-16.
6. SCULL DA. Pseudoseizures or non-epileptic seizures (NES); 15 synonyms. J Neurol Neurosurg Psychiatr 1997;
62: 200.
7. STONE J, CAMPBELL K, SHARMA N et al. What should we call pseudoseizures? The patient's perspective.
Seizure 2003; 12: 568-72.
8. WORLD HEALTH ORGANIZATION. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical
Description and Diagnostic Guidelines. Geneva, World Health Organization, 1992.
9. COOK M. Differential diagnosis of epilepsy. In: S Shorvon et al (Eds), The Treatment of Epilepsy (Second Edition).
Oxford, Blackwell, 2004; 64-73.
10. ANDERMANN F. Non-epileptic paroxysmal neurologic events. In JR Gater, AJ Rowan AJ (Eds). Non-epileptic
Seizures (Second Edition). Boston, Butterworth Heinemann, 2000; 51-69.
11. ALPER K, DEVINSKY O, PERRINE K et al. Psychiatric classification of nonconversion nonepileptic seizures.
Arch Neurol 1995; 52: 199-201.
12. TONI C, CASSANO GB, PERUGI G et al. Psychosensorial and related phenomena in panic disorder and in
temporal lobe epilepsy. Compr Psychiatry 1996; 37: 125-33.
13. LAMBERT MV, SIERRA M, PHILLIPS ML et al. The spectrum of organic depersonalization: a review plus four
new cases. J Neuropsychiat Clin Neurosci 2002; 14: 141-54.
14. KRISTENSEN O, ALVING J. Pseudoseizures – risk factors and prognosis. Acta Neurol Scand 1992; 85: 177-80.
15. KOTSOPOULOS IA, DE KROM MC, KESSELS AG et al. The diagnosis of epileptic and non-epileptic seizures.
Epilepsy Res 2003; 57: 59-67.
16. BOWMAN ES, MARKAND ON. Psychodynamics and psychiatric diagnoses of pseudoseizure subjects. Am J
Psychiatry 1996; 153: 57-63.
17. ALPER K, DEVINSKY O, PERRINE K et al. Nonepileptic seizures and childhood sexual and physical abuse.
Neurology 1993; 43: 1950-3.
18. LEMPERT T, SCHMIDT D. Natural history and outcome of psychogenic seizures: a clinical study in 50 patients.
J Neurol 1990; 237: 35-8.
19. REUBER M, FERNANDEZ G, BAUER J et al. Diagnostic delay in psychogenic nonepileptic seizures. Neurology
2002; 58: 493-5.
20. MELLERS JDC. The approach to patients with ‘non-epileptic seizures’. Postgrad Med J 2005; 81(958): 498-504.
21. DE TOLEDO JC, RAMSEY RE. Patterns of involvement of facial muscles during epileptic and nonepileptic
events: review of 654 events. Neurology 1996; 47: 621-5.
22. WILKUS RJ, DODRILL CB, THOMPSON PM. Intensive EEG Monitoring and psychological studies of patients
with pseudoepileptic seizures. Epilepsia 1984; 25: 100-7.
23. MOORE PM, BAKER GA. Non-epileptic attack disorder: a psychological perspective. Seizure 1997; 6: 429-34.
24. WALCZAK TS, PAPACOSTAS S, WILLIAMS DT et al. Outcome after diagnosis of psychogenic nonepileptic
seizures. Epilepsia 1995; 36: 1131-7.
25. BINZER M, STONE J, SHARPE M. Recent onset pseudoseizures clues to aetiology. Seizure 2004; 13: 146-55.
26. KRISHNAMOORTHY ES, BROWN RJ, TRIMBLE MR. Personality and psychopathology in Nonepileptic attack
disorder and epilepsy: a prospective study. Epilepsy Behav 2001; 2: 418-22.
27. VAN MERODE T, TWELLAAR M, KOTSOPOULOS IA et al. Psychological characteristics of patients with
newly developed psychogenic seizures. J Neurol Neurosurg Psychiatry 2004; 75: 1175-7.
28. HENRY J, WOODRUFF GAJ. A diagnostic sign in states of apparent unconsciousness. Lancet 1978; 2: 920-1.
29. ROBIN JJ, TOLAN JD, ARNOLD JW. Ten-year experience with abnormal EEGs in asymptomatic adult males.
Aviation Space Env Med 1978; 49: 732-6.
30. GREGORY RP, OATES T, MERRY RTG. Electroencephalogram epileptiform abnormalities in candidates for
aircrew training. Electroencephalogr Clin Neurophysiol 1993; 86: 75-7.
31. REUBER M, FERNANDEZ G, BAUER J et al. Interictal EEG abnormalities in patients with psychogenic non-
epileptic seizures. Epilepsia 2002; 43: 1013-20.
32. DE LA FUENTE D, TUGENDHAFT P, MAVROUDAKIS M. Electroencephalographic abnormalities in
borderline personality disorder. Psychiatry Res 1998; 77: 131-8.
33. KAPUR J, PILLAI A, HENRY TR. Psychogenic elaboration of simple partial seizures. Epilepsia 1995; 36: 1126-
30.
34. BARE MA, BURNSTINE TH, FISHER RS et al. Electroencephalographic changes during simple partial seizures.
Epilepsia 1994; 35: 715-20.
35. WILLIAMSON PD, SPENCER DD, SPENCER SS et al. Complex partial seizures of frontal lobe origin. Ann
Neurol 1985; 18: 497-504.
36. SAYGI S, KATZ A, MARKS DA et al. Frontal lobe partial seizures and psychogenic seizures: comparison of
clinical and ictal characteristics. Neurology 1992; 42: 274-7.
37. THACKER K, DEVINSKY O, PERRINE K et al. Nonepileptic seizures during apparent sleep. Ann Neurology
1993; 33: 414-8.
38. DERICIOGLU N, SAYGI S, CIGER A. The value of provocation methods in patients suspected of having non-
epileptic seizures. Seizure 1999; 8: 152-6.
39. McGONIGAL A, OTO M, RUSSELL AJC et al. Outpatient video EEG recording in the diagnosis of non-epileptic
seizures: a randomised controlled trial of simple suggestion techniques. J Neurol Neurosurg Psychiatry 2002; 72:
549-551.
40. CASCINO GD. Video-EEG monitoring in adults. Epilepsia 2002; 43 (Suppl 3): 80-93.
41. TRIMBLE MR. Pseudoseizures. Neurologic Clinics 1986; 4: 531-47.
42. ORIBE E, AMINI R, NISSENBAUM E et al. Serum prolactin concentrations are elevated following syncope.
Neurology 1996; 47: 60-62.
43. ALVING J. Serum prolactin levels are elevated also after pseudo-epileptic seizures. Seizure 1998; 7: 85-9.
44. HOLMES EA, BROWN RJ, MANSELL W et al. Are there two qualitatively distinct forms of dissociation? A
review and some clinical implications. Clin Psychol Rev 2005; 25: 1-23.
45. BINZER M, STONE J, SHARPE M. Recent onset pseudoseizures clues to aetiology. Seizure 2004; 13: 146-55.
46. ALPER K, DEVINSKY O, PERRINE K et al. Nonepileptic seizures and childhood sexual and physical abuse.
Neurology 1993; 43: 1950-3.
47. REILLY J, BAKER GA, RHODES J et al. The association of sexual and physical abuse with somatization:
Characteristics of patients presenting with irritable bowel syndrome and non-epileptic attack disorder.
Psychological Med 1999; 29: 399-406.
48. SILVER LB. Conversion disorder with pseudoseizures in adolescence: a stress reaction to unrecognized and
untreated learning disabilities. J Am Acad Child Psychiatry 1982; 21: 508-12.
49. KRISHNAMOORTHY ES, BROWN RJ, TRIMBLE MR. Personality and psychopathology in Nonepileptic attack
disorder and epilepsy: a prospective study. Epilepsy Behav 2001; 2: 418-22.
50. REUBER M, PUKROP R, BAUER J et al. Multidimensional assessment of personality in patients with
psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry 2004; 75: 743-8.
51. BROWN RJ, SCHRAG A, TRIMBLE MR. Dissociation, childhood interpersonal trauma, and family functioning
in patients with somatization disorder. Am J Psychiatr 2005; 162: 899-905.
52. SLAVNEY PR. Pseudoseizures, sexual abuse and hermeneutic reasoning. Comprehensive Psychiatry 1994; 35:
471-7.
53. FARIAS ST, THIEMAN C, ALSAADI TM. Psychogenic nonepileptic seizures: acute change in event frequency
after presentation of the diagnosis. Epilepsy Behav 2003; 4: 424-9.
54. LA FRANCE WC, DEVINSKY O. Treatment of non-epileptic seizures. Epilepsy Behav 2002; 3: S19-23.
55. MONTGOMERY JM, ESPIE CA. Behavioural management of hysterical pseudoseizures. Behav Psychother 1986;
14: 334-340.
56. LACHENMEYER JR, OLSEN ME. Behaviour modification in the treatment of pseudoseizures: a case report.
Behav Psychother 1990; 18: 73-78.
57. GOODWIN J, SIMMS M, BERGMAN R. Hysterical seizures: a sequel to incest. Am J Orthopsychiatry 1979; 49:
698-703.
58. GROSS M. Pseudoepilepsy: a study in adolescent hysteria. Am J Psychiatry 1979; 136: 210-3
59. RUSCH MD, MORRIS GL, ALLEN L, LATHROP L. Psychological treatment of non-epileptic events. Epilepsy
Behav 2001; 2: 277-83.
60. ZAROFF CM, MYERS L, BAR WB et al. Group psychoeducation as treatment for psychological nonepileptic
seizures. Epilepsy Behav 2004; 5: 587-92.
61. CHEMALI Z, MEADOWS M. The use of eye movement desensitization and reprocessing in the treatment of
psychogenic seizures. Epilepsy Behav 2004; 784-7.
62. CHALDER T. Non-epileptic attacks: A cognitive behavioural approach in a single case approach with a four-year
follow-up. Clin Psychol Psychother 1996; 3: 291-7.
63. GOLDSTEIN LH, DEALE AC, MITCHELL-O’MALLEY S et al. An evaluation of cognitive behavioral therapy
as a treatment for dissociative seizures. A pilot study. Cognitive Behav Neurol 2004; 17: 41-9.
64. GOLDSTEIN LH. Assessment of patients with psychogenic non-epileptic seizures: psychogenic non-epileptic
seizures pose a management problem. J Neurol Neurosurg Psychiatry 2004; 75: 667-8.
65. DUNCAN R, OTO M, RUSSELL AJ, CONWAY P. Pseudosleep events in patients with psychogenic non-epileptic
seizures: prevalence and associations. J Neurol Neurosurg Psychiatry 2004; 75: 1009-12.
66. GOLDSTEIN LH. MELLERS JD. Ictal symptoms of anxiety, avoidance behaviour, and dissociation in patients
with dissociative seizures. J Neurol Neurosurg Psychiatr 2006; 77: 616-21.
67. HOLTKAMP, MARTIN MD, OTHMAN J et al. Diagnosis of psychogenic nonepileptic status epilepticus in the
emergency setting. Neurology 2006; 66: 1727-9.
68. SHARPE D. FAYE C. Non-epileptic seizures and child sexual abuse: a critical review of the literature. Clin
Psycholog Rev 2006; 26: 1020-40.
69. REUBER M, HOWLETT S, KEMP S. Psychologic treatment of patients with psychogenic nonepileptic seizures.
Expert Rev Neurother 2005; 5: 737-52.
70. OTO M, ESPIE C, PELOSI A et al. The safety of antiepileptic drug withdrawal in patients with non-epileptic
seizures. J Neurol Neurosurg Psychiatr 2005; 76: 1682-5.
71. LAFRANCE WC Jr, KEITNER GI, PAPANDONATOS GD et al. Pilot pharmacologic randomized controlled trial
for psychogenic nonepileptic seizures. Neurology 2010; 75: 1166-73
72. MAYOR RH, GRUNEWALD R, REUBER M. Long-term outcome of brief augmented psychodynamic
interpersonal therapy for psychogenic nonepileptic seizures: seizure control and healthcare utilization. Epilepsia
2010; 51: 1169-76.
73. LAFRANCE WC, MILLER IW, RYAN CE et al. Cognitive behavioural therapy for psychogenic nonepileptic
seizures. Epilepsy Behav 2009; 14: 591-6.
74. KUYK J, SIFFELS MC, BAKVIS P et al. Psychological treatment of patients with psychogenic non-epileptic
seizures: an outcome study. Seizure 2008; 17: 595-603.
75. GOLDSTEIN LH, CHALDER T, CHIGWEDERE C, et al. Cognitive-behavioral therapy for psychogenic
nonepileptic seizures: a pilot RCT. Neurology 2010; 74: 1986-94.
76. McKENZIE P, OTO M, RUSSELL A et al. Early outcomes and predictors in 260 patients with psychogenic
nonepileptic attacks (PNEA). Neurology 2010; 74: 64-9.
77. AVBERSEK A, SISODIYA S. Does the primary literature provide support for clinical signs used to distinguish
psychogenic nonepileptic seizures from epileptic seizures? J Neurol Neurosurg Psychiatry 2010; 81:719-25.
78. REUBER M, JAMNADAS-KHODA J, BROADHURST M et al. Psychogenic nonepileptic seizure manifestations
reported by patients and witnesses. Epilepsia 2011; 52: 2028-35.
79. GOLDSTEIN LH, MELLERS JDCM. Recent developments in our understanding of the semiology and treatment
of psychogenic non-epileptic seizures. Curr Neurol Neurosci Rep 2012; 12: 436-44.
80. STONE J, CARSON A. The unbearable lightheadedness of seizing: willful submission to dissociative (non-
epileptic) seizures. J Neurol Neurosurg Psychiatry 2013; 84(7): 822-4.
81. LAFRANCE WC Jr, BAIRD GL, BARRY JJ et al. Multicenter pilot treatment trial for psychogenic nonepileptic
seizures: a randomized clinical trial. JAMA Psychiatry 2014; 7: 997-1005.
82. CODES. COgnitive behavioural therapy for Dissociative (non-Epileptic) Seizures: a randomised controlled trial.
www.codestrial.org.